Hepatosplenic T-cell lymphoma and TNF-α inhibitors.
Expert Rev Hematol, 2009/12;2(6):611-4.
PMID: 21082951DOI: 10.1586/ehm.09.62
Impact factor: 2.819
MeSH terms
Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Humans; Immunosuppression Therapy; Infliximab; Liver Neoplasms; Lymphoma, T-Cell; Male; Splenic Neoplasms; Tumor Necrosis Factor-alpha; Young Adult
More resources
EndNote: Download